› Forums › General Melanoma Community › ASCO 2017: The kitchen sink – atezo (anti-PD-L1) plus BRAF/MEK
- This topic has 4 replies, 4 voices, and was last updated 8 years, 5 months ago by
marta010.
- Post
-
- June 15, 2017 at 1:11 pm
Here's a look at the whole she bang:
Combining the efficacy of BRAF/MEK (though one must be BRAF+ and that's only about 1/2 of us) with the durability of immunotherapy would be a great thing indeed! Keep working researchers! Keep working! – c
- Replies
-
-
- June 16, 2017 at 11:16 am
Hi Celeste, just came across this interview with Georgina Long from Australia on new results with ipi/nivo and brain mets. Take care!!!!Ed http://ecancer.org/video/6018/updates-in-melanoma–treating-braf-and-brain-metastases.php
-
- June 16, 2017 at 1:00 pm
Thanks, Ed! I added the link to my ASCO brain met post! The news to me was that they are going to try a "different dosing schedule" for ipi in the ipi/nivo combo in order to try to decrease side effects. Wonder what the plan is….hmmmm… You're awsome possum! c
-
- June 16, 2017 at 1:01 pm
I think my husband has been informally participating in his own clinical trial of one patient! He has been on Tafinlar for 3+ years while also receiving Keytruda. Only received 7 infusions before having issues with brain edema last September but is still taking Tafinlar. He was never able to tolerate the addition of Mekinist and is on 3/4 dose of Tafinlar. Still has some active tumors but has been stable since stopping the Keytruda infusions.
Ann
- You must be logged in to reply to this topic.